FDA

Subscribe to FDA via RSS

HELP Committee Approves Bill to Address Infant Formula Shortage

Posted on June 17, 2022

The Senate Health, Education, Labor and Pensions (HELP) Committee has approved the FDA Safety and Landmark Advancements Act of 2022 (FDASLA) to introduce policies in response to the infant formula

…
Continue Reading HELP Committee Approves Bill to Address Infant Formula Shortage

FDA Responds to Severe Weather Incidents

Posted on June 16, 2022

On June, 6 2022, FDA released an online resource page for human and animal food producers who may be affected by flooding and severe weather incidents. It identifies federal and

…
Continue Reading FDA Responds to Severe Weather Incidents

Senate Bill to Revise and Reassess GRAS Program

Posted on June 1, 2022

On May 27, Senator Edward J. Markey (D-Mass.), alongside Senators Richard Blumenthal (D-Conn.) and Elizabeth Warren (D-Mass)., introduced the Ensuring Safe and Toxic-Free Foods Act, which is described as “comprehensive

…
Continue Reading Senate Bill to Revise and Reassess GRAS Program

FDA Webinar on Action Levels for Lead in Juice

Posted on May 26, 2022

FDA will hold a webinar on Tuesday, June 14, 2022, at 1:00 pm (ET) to provide an overview of the recent draft guidance that the Agency issued on action levels

…
Continue Reading FDA Webinar on Action Levels for Lead in Juice

FDA Updates Agricultural Water Protocol

Posted on May 19, 2022

As previously reported, on July 30, 2020, FDA worked with EPA to release a protocol to evaluate the efficacy of antimicrobial pesticides in agricultural water. The protocol established an

…
Continue Reading FDA Updates Agricultural Water Protocol

House Bill To Give FDA More Funding to Address Formula Shortage

Posted on May 18, 2022

On May 17, House Appropriations Committee Chair Rosa DeLauro (D-CT) introduced H.R. 7790, a supplemental appropriations bill to provide $28 million in emergency funding to address the shortage of

…
Continue Reading House Bill To Give FDA More Funding to Address Formula Shortage

FDA Finalizes Guidance on Reducing Microbial Hazards in Seed for Sprouting

Posted on May 16, 2022

As covered on this blog, FDA announced a draft guidance on June 25, 2019 for the seed sprouting industry that provides recommended steps to prevent adulteration for firms involved

…
Continue Reading FDA Finalizes Guidance on Reducing Microbial Hazards in Seed for Sprouting

FDA Works to Improve Supply of Formula Products

Posted on May 12, 2022

On May 10, 2022, FDA published a news release in which it highlighted its efforts to improve the supply of infant and specialty formula products. This follows a warning from

…
Continue Reading FDA Works to Improve Supply of Formula Products

FDA Issues Warning Letters to 11 Supplement Companies

Posted on May 11, 2022

On May 9, the FDA posted warning letters to 11 companies for selling adulterated dietary supplements that either contained new dietary ingredients (NDIs) for which the FDA had not received

…
Continue Reading FDA Issues Warning Letters to 11 Supplement Companies

FDA Issues Delta-8 THC Warning Letters

Posted on May 5, 2022

On May 4, 2022, FDA announced that it had issued warning letters to five companies selling products (including gummies, capsules, tinctures, lotions, vaping products, pet products, and hand sanitizers) labeled

…
Continue Reading FDA Issues Delta-8 THC Warning Letters